Literature DB >> 3797616

Tricyclic antidepressants in the treatment of panic and anxiety disorders.

D V Sheehan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3797616     DOI: 10.1016/s0033-3182(86)72597-8

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  7 in total

1.  Treatment of negative crises (panic attacks).

Authors:  G M Dyukova; I P Shepeleva; O V Vorob'eva
Journal:  Neurosci Behav Physiol       Date:  1992 Jul-Aug

2.  The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.

Authors:  T Paslawski; D Treit; G B Baker; M George; R T Coutts
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

Review 3.  Overview of panic disorder.

Authors:  J C Ballenger
Journal:  Trans Am Clin Climatol Assoc       Date:  1994

4.  Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat.

Authors:  D J Fontana; T J Carbary; R L Commissaris
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine.

Authors:  R J Blanchard; J K Shepherd; R J Rodgers; L Magee; D C Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential "animal model" for the study of panic disorder?

Authors:  D J Fontana; R L Commissaris
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  A risk-benefit assessment of pharmacological treatments for panic disorder.

Authors:  J A Bennett; M Moioffer; S P Stanton; M Dwight; P E Keck
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.